XML 29 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Goodwill, Finite-Lived, and Indefinite-Lived Intangibles
9 Months Ended
Sep. 30, 2021
Goodwill Disclosure [Abstract]  
Goodwill, Finite-Lived, and Indefinite-Lived Intangibles Goodwill, Finite-Lived, and Indefinite-Lived Intangibles
    Changes in the carrying amount of goodwill for the nine months ended September 30, 2021 and the year ended December 31, 2020 are reflected in the following table.
September 30, 2021December 31, 2020
(Unaudited)
 (In thousands)
Beginning Balance$949,037 $952,404 
Additions— 11,241 
Purchase accounting adjustments1,201 725 
Foreign currency translation adjustments(9,638)(15,333)
Ending Balance$940,600 $949,037 

    The carrying value of finite-lived and indefinite-lived intangible assets at September 30, 2021 and December 31, 2020 are as follows:
September 30,
2021
December 31,
2020
(Unaudited)
 (In thousands)
Finite-lived intangible assets:  
Customer relationships$102,436 $96,616 
Developed technology20,243 19,867 
Dealer network6,548 6,653 
Airport contracts4,451 4,523 
Trademarks2,694 2,700 
Store networks2,401 2,440 
Brand882 896 
Non-compete agreements724 759 
Database212 212 
Backlog140 140 
Total intangibles140,731 134,806 
Accumulated amortization(91,419)(83,926)
Finite-lived intangibles, net$49,312 $50,880 
Indefinite-lived intangibles:  
Customer/territorial relationships$16,647 $21,647 

As a part of the 2009 acquisition of E-Z Data Ebix recognized a $14.2 million indefinite-lived intangible asset associated with acquired corporate customer relationships. During the third quarter 2020, the Company identified a potential indicator of impairment and performed a quantitative analysis to test for impairment. The Company determined the fair value of the intangible assets exceeded its carrying value, however the Company determined that the intangible asset no longer had an indefinite life. The Company has reclassified the $14.2 million to finite-lived and will amortize the value of this intangible over an estimated remaining useful life of 15 years.

The Company recorded a $6.2 million impairment charge in the fourth quarter of 2020 related to the IHC customer relationship indefinite-lived intangible asset associated with the Company's EbixHealth JV. In addition, the Company concluded that the remaining IHC customer relationship intangible was no longer indefinite-lived. The Company amortizes this intangible over the remaining estimated useful life of ten years.     
Amortization expense recognized in connection with acquired intangible assets was $2.7 million and $7.9 million for the three and nine month periods ended September 30, 2021, respectively, and $2.4 million and $7.1 million for the three and nine month periods ended September 30, 2020, respectively.